Research location

New Haven

Connecticut, United States

Published trials1,930

Site observations2,130

Linked trials published1,930

Page3 / 39

Research activity in New Haven

Connecticut, United States

CureCurrent currently publishes aggregate city-level research activity for this location: 1,930 trials and 2,130 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in New Haven

1,930 linked trials · page 3 of 39

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)NCT06881784 · 2025-05-06 · 1 site observation

Exploring the Utility of [18F]3F4AP for Demyelination ImagingNCT06999434 · 2025-05-05 · 1 site observation

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine TumorsNCT07080242 · 2025-04-28 · 1 site observation

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung CancerNCT06287775 · 2025-04-08 · 1 site observation

A Study of PHST001 in Advanced Solid TumorsNCT06840886 · 2025-03-31 · 1 site observation

BBO-11818 in Adult Subjects With KRAS Mutant CancerNCT06917079 · 2025-03-31 · 1 site observation

A Study With NKT5097 for Adults With Advanced/Metastatic Solid TumorsNCT07029399 · 2025-03-25 · 1 site observation

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)NCT06841354 · 2025-03-16 · 1 site observation

Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart FailureNCT06526988 · 2025-03-06 · 1 site observation

DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHYNCT06749210 · 2025-02-19 · 1 site observation

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate CancerNCT06800313 · 2025-02-06 · 1 site observation

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRENCT06777368 · 2025-02-06 · 1 site observation

Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast CancerNCT06888388 · 2025-02-01 · 1 site observation

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)NCT06568939 · 2025-01-20 · 1 site observation

Stress and Pain in People Living With HIVNCT06784908 · 2025-01-16 · 1 site observation

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)NCT06739122 · 2025-01-10 · 1 site observation

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 MutationsNCT06706076 · 2025-01-09 · 1 site observation

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionNCT06736574 · 2024-12-19 · 1 site observation

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)NCT06667076 · 2024-12-16 · 1 site observation

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid TumorsNCT06747585 · 2024-12-16 · 1 site observation

First in Human Study of TUB-030 in Patients With Advanced Solid TumorsNCT06657222 · 2024-12-13 · 1 site observation

TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV RiskNCT05576350 · 2024-12-09 · 1 site observation

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)NCT06667908 · 2024-12-06 · 1 site observation

Craving Network NeurofeedbackNCT06426693 · 2024-11-27 · 1 site observation

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationNCT05552157 · 2024-11-22 · 1 site observation

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationNCT06647498 · 2024-11-22 · 1 site observation

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced MalignanciesNCT06458712 · 2024-11-21 · 1 site observation

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast CancerNCT06369285 · 2024-11-19 · 1 site observation

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)NCT06116682 · 2024-11-19 · 1 site observation

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)NCT06672549 · 2024-11-18 · 1 site observation

Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM AccessNCT06658067 · 2024-11-12 · 1 site observation

PRIDE III Prison Interventions and HIV Prevention CollaborationNCT06962033 · 2024-11-05 · 1 site observation

The CDK4/6 Inhibitor Dosing Knowledge (CDK) StudyNCT06377852 · 2024-10-29 · 2 site observations

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXdNCT06533826 · 2024-10-29 · 1 site observation

Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast CancerNCT06582615 · 2024-10-28 · 1 site observation

A First-in-Human Study of MEN2312 in Adults With Advanced Breast CancerNCT06638307 · 2024-10-25 · 1 site observation

A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaNCT06368817 · 2024-10-22 · 1 site observation

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)NCT06623422 · 2024-10-21 · 1 site observation

Open-Label Psilocybin Study in Transdiagnostic PopulationNCT06442423 · 2024-10-17 · 1 site observation

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant TherapyNCT05989347 · 2024-10-15 · 1 site observation

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast CancerNCT06551116 · 2024-10-10 · 2 site observations

Registry for Stage 2 Type 1 DiabetesNCT06481904 · 2024-09-27 · 1 site observation

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceNCT06492616 · 2024-09-27 · 1 site observation

Imaging Depression in Parkinson's DiseaseNCT06402955 · 2024-09-01 · 1 site observation

A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's DiseaseNCT06565195 · 2024-08-27 · 1 site observation

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)NCT06031688 · 2024-08-08 · 1 site observation

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational DiabetesNCT06445946 · 2024-08-01 · 1 site observation

Mechanisms of Diuretic Resistance in Heart Failure, Aim 3NCT06209359 · 2024-07-24 · 1 site observation

Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)NCT05776563 · 2024-07-19 · 1 site observation

Pre-Operative Window of ET to Inform RT Decisions (POWER II)NCT06507618 · 2024-07-19 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.